SCM
Suvretta Capital Management Portfolio holdings
AUM
$2.65B
This Quarter Return
-11.5%
1 Year Return
+18.59%
3 Year Return
+180.23%
5 Year Return
+278.12%
10 Year Return
+1,101.07%
AUM
$2.63B
AUM Growth
+$2.63B
(-20%)
Cap. Flow
-$267M
Cap. Flow
% of AUM
-10.16%
Top 10 Holdings %
Top 10 Hldgs %
36.43%
Holding
110
New
23
Increased
22
Reduced
18
Closed
21
Top Buys
| 1 |
Canadian Pacific Kansas City
CP
|
$44.3M |
| 2 |
Royalty Pharma
RPRX
|
$44.3M |
| 3 |
XYZ
Block, Inc.
XYZ
|
$41.8M |
| 4 |
Viatris
VTRS
|
$40.6M |
| 5 |
Fidelity National Information Services
FIS
|
$40.6M |
Top Sells
| 1 |
Amazon
AMZN
|
$147M |
| 2 |
Microsoft
MSFT
|
$88.8M |
| 3 |
S&P Global
SPGI
|
$84.8M |
| 4 |
Charles Schwab
SCHW
|
$82.9M |
| 5 |
Johnson & Johnson
JNJ
|
$73.6M |
Sector Composition
| 1 | Healthcare | 56.33% |
| 2 | Industrials | 11.58% |
| 3 | Consumer Discretionary | 10.43% |
| 4 | Technology | 7.11% |
| 5 | Financials | 5.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Royalty Pharma
RPRX
$15.6B
| $129M | 4.92% | 3,078,506 +1,052,896 | +52% | +$44.3M |
|
2
UnitedHealth
UNH
$281B
| $124M | 4.71% | 240,997 | – | – |
|
3
Union Pacific
UNP
$133B
| $113M | 4.31% | 532,015 -81,613 | -13% | -$17.4M |
|
4
Las Vegas Sands
LVS
$39.6B
| $97.5M | 3.71% | 2,903,711 +628,429 | +28% | +$21.1M |
|
5
Humana
HUM
$36.5B
| $92.5M | 3.52% | 197,668 +8,780 | +5% | +$4.11M |
|
6
Otis Worldwide
OTIS
$33.9B
| $91.7M | 3.49% | 1,297,480 | – | – |
|
7
IQVIA
IQV
$32.4B
| $85.1M | 3.23% | 392,045 +5,335 | +1% | +$1.16M |
|
|
ITCI
8
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $76.4M | 2.91% | 1,338,700 -193,223 | -13% | -$11M |
|
9
Estee Lauder
EL
$33B
| $74.6M | 2.84% | 292,979 -79,496 | -21% | -$20.2M |
|
10
Kura Oncology
KURA
$686M
| $73.6M | 2.8% | 4,017,000 +123,981 | +3% | +$2.27M |
|
11
Tapestry
TPR
$21.2B
| $68.6M | 2.61% | 2,247,709 -72,391 | -3% | -$2.21M |
|
12
Centene
CNC
$14.3B
| $68.3M | 2.6% | 807,438 -389,768 | -33% | -$33M |
|
13
Mastercard
MA
$538B
| $66M | 2.51% | 209,111 +18,168 | +10% | +$5.73M |
|
14
Thermo Fisher Scientific
TMO
$186B
| $65.9M | 2.51% | 121,375 +6,306 | +5% | +$3.43M |
|
|
15
Microsoft
MSFT
$3.77T
| $64.2M | 2.44% | 250,157 -345,590 | -58% | -$88.8M |
|
16
Visa
V
$683B
| $64M | 2.43% | 324,818 -113,172 | -26% | -$22.3M |
|
|
MRTX
17
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $63.9M | 2.43% | 951,986 +441,655 | +87% | +$29.6M |
|
18
Danaher
DHR
$147B
| $55.3M | 2.1% | 218,222 -14,348 | -6% | -$3.64M |
|
19
Agios Pharmaceuticals
AGIO
$2.19B
| $51.5M | 1.96% | 2,321,800 +1,144,426 | +97% | +$25.4M |
|
20
Arcellx
ACLX
$3.85B
| $44.7M | 1.7% | 2,470,559 +937,500 | +61% | +$17M |
|
21
Cencora
COR
$56.5B
| $44.5M | 1.69% | 314,691 -68,447 | -18% | -$9.68M |
|
|
22
Canadian Pacific Kansas City
CP
$69.9B
| $44.3M | 1.68% | +634,056 | New | +$44.3M |
|
|
XYZ
23
Block, Inc.
XYZ
$48.5B
| $41.8M | 1.59% | +679,676 | New | +$41.8M |
|
24
Insmed
INSM
$28.8B
| $41M | 1.56% | 2,078,680 +760,248 | +58% | +$15M |
|
|
25
Viatris
VTRS
$12.3B
| $40.6M | 1.55% | +3,881,900 | New | +$40.6M |
|